Get the Stockscreener App
86.38
2.70%
-2.40
After Hours:
86.80
0.42
+0.49%
Tempus Ai Inc stock is traded at $86.38, with a volume of 6.72M.
It is down -2.70% in the last 24 hours and up +30.21% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$88.78
Open:
$89.26
24h Volume:
6.72M
Relative Volume:
0.67
Market Cap:
$14.57B
Revenue:
$803.32M
Net Income/Loss:
$-709.10M
P/E Ratio:
-11.07
EPS:
-7.8003
Net Cash Flow:
$-212.68M
1W Performance:
+8.49%
1M Performance:
+30.21%
6M Performance:
+89.85%
1Y Performance:
+90.06%
1-Day Range:
$85.92
$90.34
1-Week Range:
$77.17
$91.06
52-Week Range:
$31.36
$91.45
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
86.38 | 13.58B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
VEEV
Veeva Systems Inc
|
276.43 | 45.01B | 2.97B | 809.93M | 1.33B | 4.87 |
|
DOCS
Doximity Inc
|
71.03 | 12.92B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
92.49 | 7.88B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.36 | 7.06B | 906.14M | -52.62M | 89.62M | -0.3621 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-02-25 | Initiated | H.C. Wainwright | Buy |
| Apr-21-25 | Initiated | BTIG Research | Buy |
| Feb-25-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-05-25 | Resumed | TD Cowen | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-09-24 | Initiated | Guggenheim | Buy |
| Nov-11-24 | Downgrade | Stifel | Buy → Hold |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
Tempus AI (NASDAQ:TEM) Trading 2.8% HigherHere's What Happened - MarketBeat
4,658 Shares in Tempus AI, Inc. $TEM Acquired by MetLife Investment Management LLC - MarketBeat
Advisors Asset Management Inc. Purchases 15,342 Shares of Tempus AI, Inc. $TEM - MarketBeat
Why Tempus AI Stock Soared Nearly 14% Higher Today - sharewise.com
Tempus AI stock is cheap as Murrey Math Lines points to more gains - CryptoRank
Tempus AI secures 510(k) for Pixel - AuntMinnie
Tempus AI stock rises as H.C. Wainwright raises price target on FDA clearance - Investing.com UK
Artificial Intelligence Stocks To Watch NowSeptember 11th - MarketBeat
Traders Buy High Volume of Tempus AI Call Options (NASDAQ:TEM) - MarketBeat
Tempus gets FDA OK for AI-driven cardiac image analysis - Crain's Chicago Business
Tempus AI Stock (TEM) Rallies as FDA Approves AI Cardiac Imaging Platform - TipRanks
Tempus AI Receives U.S. FDA Special 510k Clearance for Updated Tempus Pixel Device - MarketScreener
Tempus AI: Is TEM Stock A 10x Growth Story? - Forbes
Tempus AI (TEM) Touches 7-Month High on Pixel FDA Approval - ca.finance.yahoo.com
Nancy Pelosi's AI Pick Set for Gains After Price Target Update - TheStreet Pro
Why Tempus AI Is A High Stakes High Rewards Play? - Trefis
Tempus AI: Temporarily Too ExpensiveSell (NASDAQ:TEM) - Seeking Alpha
Tempus (TEM) Stock Jumps 13.6%: Will It Continue to Soar? - Yahoo Finance
Tempus AI price target raised to $98 from $90 at H.C. Wainwright - TipRanks
Arete Wealth Advisors LLC Makes New $314,000 Investment in Tempus AI, Inc. $TEM - MarketBeat
KLAR, FIG, TEM: Cathie Wood Loads Up on Hot IPO Stocks, Sells Tempus AI - TipRanks
Temasek Holdings Private Ltd Takes Position in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI Stock Soars on FDA Clearance and Blowout Earnings - NAI500
21,694 Shares in Tempus AI, Inc. $TEM Bought by Scientech Research LLC - MarketBeat
Cathie Wood's Ark Pivots: Sells Tempus AI After FDA Win, Loads Up On Amazon, Figma And This Trendy Crypto Stock - Benzinga
Cathie Wood’s ARK buys Klarna stock, sells Tempus AI amid market shifts - Investing.com India
Tempus AI jumps on FDA clearance of AI-enabled tool to analyze cardiac MRIs - Sherwood News
Northwestern Medicine Integrates Tempus AI’s “David” Clinical Assistant into EHR Platform - Yahoo Finance
Why It Might Be Time To Take Profits In This Top 8% Medtech - Investor's Business Daily
Is Tempus AI’s Stock a Hidden Gem? - StocksToTrade
Tempus AI’s Stock: Rise or Fall? - timothysykes.com
Tempus AI Gains FDA Clearance For Updated Pixel To Boost Accuracy And Efficiency In Cardiac Imaging - Yahoo Finance
Tempus Shares Jump on FDA's Special Clearance for Tempus Pixel - MarketScreener
Tempus AI Shares Jump After FDA Approves Updated Cardiac Imaging Platform - MSN
Tempus gets U.S. FDA clearance for updated Tempus Pixel Device - Seeking Alpha
Tempus AI, Inc. Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device - MarketScreener
Tempus AI stock soars after FDA clearance for cardiac imaging platform - Investing.com Nigeria
Tempus AI stock soars after FDA clearance for cardiac imaging platform By Investing.com - Investing.com South Africa
Tempus AI: Rapid Growth or Future Decline? - StocksToTrade
Tempus AI Gets FDA's Clearance for Updated Tempus Pixel Cardiac Imaging Platform - MarketScreener
Tempus AI Receives FDA Clearance For Updated Tempus Pixel - Nasdaq
Tempus AI receives FDA clearance for Tempus Pixel - TipRanks
TEM Gains Validation for PurIST Amid Evolving Cancer Care Landscape - Yahoo Finance
Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device - Yahoo Finance
Alliancebernstein L.P. Sells 576,214 Shares of Tempus AI, Inc. $TEM - MarketBeat
Invesco Ltd. Buys New Holdings in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI, Inc. (NASDAQ:TEM) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Tempus AI stock rating reiterated at Hold by Stifel amid test reimbursement ramp - Investing.com
Moderately bullish activity in tempus AI Inc Class A with shares down 1.12% - TipRanks
Why Are Stock Market Investors Talking About TempusAI Stock? - The Motley Fool
Stock Market Investors Want to Know: What's Going on With TempusAI Stock? - The Globe and Mail
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
2.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):